PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, 80 Vas. Sofias Avenue, 11528, Athens, Greece. Electronic address: eterpos@med.uoa.gr.\', \'Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.\', \'Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, 80 Vas. Sofias Avenue, 11528, Athens, Greece.\', \'Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.\', \'Hematology Laboratory Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.\', \'Second Department of Internal Medicine, Hematology Unit, Attikon University General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.\', \'Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\', \'MS Applied Information and Management Sciences, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.\', \'Department of Hematology and Lymphomas, BMT Unit, Evangelismos General Hospital, Athens, Greece.\', \'Department of Transfusion Service and Clinical Hemostasis, \'Saint Savvas\' Oncology Hospital, Athens, Greece.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0953-6205(21)00161-810.1016/j.ejim.2021.05.010
?:doi
?:hasPublicationType
?:journal
  • European journal of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34053848
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 54
?:title
  • SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34053848>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34053848>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all